These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 20460313)
1. The classification of lung carcinoma: time to change the morphology-based approach? Pelosi G; Sonzogni A; Viale G Int J Surg Pathol; 2010 Jun; 18(3):161-72. PubMed ID: 20460313 [TBL] [Abstract][Full Text] [Related]
2. Subtyping non-small cell lung cancer: relevant issues and operative recommendations for the best pathology practice. Rossi G; Pelosi G; Barbareschi M; Graziano P; Cavazza A; Papotti M Int J Surg Pathol; 2013 Aug; 21(4):326-36. PubMed ID: 23740564 [TBL] [Abstract][Full Text] [Related]
3. Accurate classification of non-small cell lung carcinoma using a novel microRNA-based approach. Bishop JA; Benjamin H; Cholakh H; Chajut A; Clark DP; Westra WH Clin Cancer Res; 2010 Jan; 16(2):610-9. PubMed ID: 20068099 [TBL] [Abstract][Full Text] [Related]
4. A reevaluation of the clinical significance of histological subtyping of non--small-cell lung carcinoma: diagnostic algorithms in the era of personalized treatments. Rossi G; Pelosi G; Graziano P; Barbareschi M; Papotti M Int J Surg Pathol; 2009 Jun; 17(3):206-18. PubMed ID: 19443885 [TBL] [Abstract][Full Text] [Related]
6. Prognostic implications of cell cycle, apoptosis, and angiogenesis biomarkers in non-small cell lung cancer: a review. Singhal S; Vachani A; Antin-Ozerkis D; Kaiser LR; Albelda SM Clin Cancer Res; 2005 Jun; 11(11):3974-86. PubMed ID: 15930332 [TBL] [Abstract][Full Text] [Related]
7. Molecular predictors of chemotherapy response in non-small-cell lung cancer. Gray J; Simon G; Bepler G Expert Rev Anticancer Ther; 2007 Apr; 7(4):545-9. PubMed ID: 17428174 [TBL] [Abstract][Full Text] [Related]
8. Lung cancer biomarkers: present status and future developments. Cagle PT; Allen TC; Olsen RJ Arch Pathol Lab Med; 2013 Sep; 137(9):1191-8. PubMed ID: 23991729 [TBL] [Abstract][Full Text] [Related]
9. P63 differentiates subtypes of nonsmall cell carcinomas of lung in cytologic samples: implications in treatment selection. Jorda M; Gomez-Fernandez C; Garcia M; Mousavi F; Walker G; Mejias A; Fernandez-Castro G; Ganjei-Azar P Cancer; 2009 Feb; 117(1):46-50. PubMed ID: 19347829 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of the prognostic role of a panel of biomarkers in stage IB-IIIA non-small cell lung cancer patients. Timotheadou E; Skarlos DV; Samantas E; Papadopoulos S; Murray S; Skrickova J; Christodoulou C; Papakostantinou C; Pectasides D; Papakostas P; Kaplanova J; Vrettou E; Karina M; Kosmidis P; Fountzilas G Anticancer Res; 2007; 27(6C):4481-9. PubMed ID: 18214064 [TBL] [Abstract][Full Text] [Related]
11. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results. Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205 [TBL] [Abstract][Full Text] [Related]
12. Prognostic role of cyclin D1 in non small cell lung cancer: an immunohistochemical analysis. Caputi M; De Luca L; Papaccio G; D'Aponte A; Cavallotti I; Scala P; Scarano F; Manna M; Gualdiero L; De Luca B Eur J Histochem; 1997; 41(2):133-8. PubMed ID: 9271706 [TBL] [Abstract][Full Text] [Related]
13. Non-small-cell lung carcinoma subtyping on cytology without the use of immunohistochemistry - can we meet the challenge? Manucha V; Wang C; Huang Y Acta Cytol; 2012; 56(4):413-8. PubMed ID: 22846184 [TBL] [Abstract][Full Text] [Related]
14. Re: Gene expression-based prognostic signatures in lung cancer: ready for clinical use? Boutros PC; Pintilie M; John T; Starmans MH; Der SD; Shepherd FA; Tsao MS; Jurisica I J Natl Cancer Inst; 2010 Nov; 102(21):1677-8; author reply 1678-9. PubMed ID: 20921041 [No Abstract] [Full Text] [Related]
15. Molecular profiling of lung carcinoma: identifying clinically useful tumor markers for diagnosis and prognosis. Dacic S Expert Rev Mol Diagn; 2007 Jan; 7(1):77-86. PubMed ID: 17187486 [TBL] [Abstract][Full Text] [Related]
16. Identification and classification of differentially expressed genes in non-small cell lung cancer by expression profiling on a global human 59.620-element oligonucleotide array. Hofmann HS; Bartling B; Simm A; Murray R; Aziz N; Hansen G; Silber RE; Burdach S Oncol Rep; 2006 Sep; 16(3):587-95. PubMed ID: 16865260 [TBL] [Abstract][Full Text] [Related]
17. Genes and pathology of non-small cell lung carcinoma. Sakashita S; Sakashita M; Sound Tsao M Semin Oncol; 2014 Feb; 41(1):28-39. PubMed ID: 24565579 [TBL] [Abstract][Full Text] [Related]
18. Translating biomarkers into clinical practice: prognostic implications of cyclophilin A and macrophage migratory inhibitory factor identified from protein expression profiles in non-small cell lung cancer. Howard BA; Zheng Z; Campa MJ; Wang MZ; Sharma A; Haura E; Herndon JE; Fitzgerald MC; Bepler G; Patz EF Lung Cancer; 2004 Dec; 46(3):313-23. PubMed ID: 15541816 [TBL] [Abstract][Full Text] [Related]